## Note
nid: 1487207112553
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Immunology_+_General_Pathology::Immunology, #AK_Step1_v11::#B&B::12_Immunology::02_Clinical::01_Hypersensitivity, #AK_Step1_v11::#FirstAid::02_Immunology::03_Immune_Responses::13_Hypersensitivity_Types, #AK_Step1_v11::#FirstAid::02_Immunology::03_Immune_Responses::13_Hypersensitivity_Types::Type_2_Hypersensitivity_Reaction, #AK_Step1_v11::#FirstAid::02_Immunology::03_Immune_Responses::15_Autoantibodies, #AK_Step1_v11::#OME::07_Immunology::11_Hypersensitivity, #AK_Step1_v11::#OME_banner::Clinical::09_Dermatology::04_Hypersensitivity, #AK_Step1_v11::#Physeo::08_Immunology::01_Immunology::20_Hypersensitivity_Reactions, #AK_Step1_v11::#Pixorize::01_Immunology::08_Hypersensitivity_Reactions::02_Type_2_Hypersensitivity_Reactions, #AK_Step1_v11::^Other::^EXPN::BGedit, #AK_Step1_v11::^Other::^FA_Updates::FA2018, #AK_Step1_v11::^Other::^HighYield::1-HighYield, #AK_Step1_v11::^Systems::Immunology::HSRs
markdown: false

### Text
<div>
  <u>Type II HSRs</u> can cause pathology by inducing
  {{c1::cellular dysfunction}}, causing <i>abnormal</i>
  <b>blockade</b> or <b>activation/inactivation</b> of downstream
  cellular processes
</div>

### Extra
<div>
  <i>Ex. Myasthenia gravis, Graves disease, Pemphigus vulgaris</i>
</div>
<div>
  <i>In <b>pemphigus vulgaris</b>, autoantibodies against
  desmoglein-1 (αDsg1) / -3 (αDsg3) <b>inactivate</b> these
  proteins, resulting in <u>loss of cell-cell adhesion</u></i>
</div>
<div>
  <i><u><img src="paste-602180184702977.jpg"></u></i>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="tmpvdvpva23.png"> <img src="tmpuvczdwzb.png">

### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/dermatology/hypersensitivity/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_6.png"></a>
</div>

### Additional Resources


### One by one

